{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["ffe46337-89df-40ed-bf66-e47b4468909b", "Q1", 401104125, "MAGNET STRATEGY GROUP", 200805, "MEDICAGO INC.", 2017, "first_quarter", "2017-04-11T15:59:26.857000-04:00", 7000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/ffe46337-89df-40ed-bf66-e47b4468909b/\", \"filing_uuid\": \"ffe46337-89df-40ed-bf66-e47b4468909b\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2017, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/ffe46337-89df-40ed-bf66-e47b4468909b/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"7000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Danielle Peters\", \"dt_posted\": \"2017-04-11T15:59:26.857000-04:00\", \"termination_date\": null, \"registrant_country\": \"Canada\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"25 Oriole Gdns\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"TORONTO\", \"registrant_state\": \"ON\", \"registrant_zip\": null, \"registrant\": {\"id\": 401104125, \"url\": \"https://lda.senate.gov/api/v1/registrants/401104125/\", \"house_registrant_id\": null, \"name\": \"MAGNET STRATEGY GROUP\", \"description\": \"Public Affairs Consulting Firm\", \"address_1\": \"88 Sheppard Street West\", \"address_2\": \"Suite 100\", \"address_3\": \"TORONTO\", \"address_4\": \"ON M2N 1M5\", \"city\": \"TORONTO\", \"state\": \"ON\", \"state_display\": \"ON\", \"zip\": \"M2N 1\", \"country\": \"CA\", \"country_display\": \"Canada\", \"ppb_country\": \"CA\", \"ppb_country_display\": \"Canada\", \"contact_name\": \"DANIELLE PETERS\", \"contact_telephone\": \"+1 416-910-4196\", \"dt_updated\": \"2024-03-06T19:00:22.152999-05:00\"}, \"client\": {\"id\": 200805, \"url\": \"https://lda.senate.gov/api/v1/clients/200805/\", \"client_id\": 12, \"name\": \"MEDICAGO INC.\", \"general_description\": \"Vaccine manufacturer\", \"client_government_entity\": false, \"client_self_select\": null, \"state\": null, \"state_display\": null, \"country\": \"CA\", \"country_display\": \"Canada\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"CA\", \"ppb_country_display\": \"Canada\", \"effective_date\": \"2016-08-01\"}, \"lobbying_activities\": [{\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"Importance of biopharmaceutical platforms to strengthen preparedness against future outbreaks in emerging infectious disease.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 64648, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIELLE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"PETERS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"Importance of biopharmaceutical platforms to strengthen preparedness against future outbreaks in emerging infectious disease.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 64648, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DANIELLE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"PETERS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}", "ON", "CA", null, null, null, "CA", "CA", "Vaccine manufacturer", 0, 0, null, null, null, null]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json", "registrant_state", "registrant_country", "registrant_house_id", "client_state", "client_ppb_state", "client_country", "client_ppb_country", "client_general_description", "client_government_entity", "affiliated_org_count", "client_entity_id", "client_government_unit_id", "client_match_method", "client_match_confidence"], "primary_keys": ["filing_uuid"], "primary_key_values": ["ffe46337-89df-40ed-bf66-e47b4468909b"], "units": {}, "query_ms": 0.956730917096138, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}